[1]赵卫,易根发,胡继红,等.Graves病介入术后甲状腺细胞凋亡因子的表达[J].介入放射学杂志,2007,(08):523.
 ZHAO Wei,YI Gen-fa,HU Ji-hong,et al.Study of the expression for apoptosis factors of thyroid cells after arterial embolization to treat hyperthyroidism caused by Graved' disease[J].journal interventional radiology,2007,(08):523.
点击复制

Graves 病介入术后甲状腺细胞凋亡因子的表达()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2007年08期
页码:
523
栏目:
血管介入
出版日期:
2007-08-15

文章信息/Info

Title:
Study of the expression for apoptosis factors of thyroid cells after arterial embolization to treat hyperthyroidism caused by Graved' disease
作者:
赵卫易根发胡继红
650032昆明医学院第一附属医院医学影像中心(赵卫、易根发、胡继红、向述天、姜永能、李莉媛、胡正琴),内分泌科(杨慧英、李红);昆明医学院病理教研室(申丽娟、张华献)
Author(s):
ZHAO WeiYI Gen-faHU Ji-hongXIANG Shu-tianJIANG Yong-nengLI Li-yuanHU Zheng-qinSHEN Li-juanZHANG Hua-xianYANG Hui-yingLI Hong.
Medical Imaging Center,The First Affiliated Hospital,Kunming Medical College,Kunming650032,China
关键词:
Graves病介入治疗细胞凋亡免疫组化
分类号:
R581.1
文献标志码:
A
摘要:
目的研究Graves病(GD)介入治疗前后凋亡调节蛋白Fas、FasL、Bcl-2、Bax、P53表达改变,了解GD介入治疗术前、术后凋亡因子表达情况及凋亡与疗效的关系。方法对15例GD患者的150μm PVA微粒及平阳霉素栓塞甲状腺动脉治疗,于术前、术后44例次成功穿刺甲状腺取标本行切片免疫组化分析,其中术前15例次、栓塞术后1年内16例次、术后1年以上13例次。采用免疫组化半定量积分法检测GD患者Fas、FasL、Bcl-2、Bax及P53表达情况。结果①术后15例中9例停药6个月以上无复发,为长期缓解,6例少量抗甲状腺药物(ATD)维持(用药量<术前用药量的1/4,甲状腺功能正常)为好转。②Fas和FasL阳性细胞数及着色程度均高于术前GD甲状腺组织(P<0.05)。③术后1年内组与术前组Bax阳性细胞数及着色程度均较强(两组比较,P>0.05),但术后1年以上Bax阳性细胞数及着色程度高于术前组(P<0.05);Bcl-2阳性细胞数及着色程度术前术后均无明显差别。④术后P53阳性细胞数及着色程度明显高于术前(P<0.05)。结论甲状腺动脉栓塞治疗GD后促凋亡基因Fas、FasL、Bax及P53表达增强,抗凋亡因子Bcl-2表达无增强。表明GD介入栓塞治疗是从甲状腺腺体细胞凋亡调节的水平发挥了有效的治疗作用。

参考文献/References:

[1]李金明,张文卿,赵玉亭,等.犬甲状腺动脉栓塞术治疗甲亢的研究[J].中华实验外科杂志,1992,9:165-166.
[2]Galkin EV,Grakov BS,Protopov AV.First clinical experience of radioendovascular functional thyroidectomy in the treatment of diffuse toxic goiter[J].Vestin Rentgenol Radiol,1994,3:29-35.
[3]梁君,杨士彬,岳玉,等.甲状腺机能亢进的介入治疗[J].介入放射学杂志,2001,10:209-211.
[4]狄镇海,王晓川,柳龙图,等.甲状腺动脉栓塞治疗Graves病[J].介入放射学杂志,2002,11:13-15.
[5]庄文权,李维多,杨建勇,等.彩色多普勒超声监测Graves病甲状腺动脉栓塞后血流变化的临床研究[J].介入放射学杂志,2003,12:98-101.
[6]Mannhein B.Nonradioative in situ hybrization application manu-al[M].Second edition primed in Germany,1996:116-157.
[7]Kawasaki H,Toyoda M,Shinohara H,et al.Expression of Sur-vivin correlates with apoptosis,proliferation and angiogenesis during human colorectal tumorigenesis[J].Cancer,2001,91:2026-2032.
[8]赵卫,丁忠祥,宋滇平,等.甲状腺动脉栓塞治疗甲亢的初步临床研究[J].云南医药,2002,23:181-183.
[9]庄文权,陈伟,肖海鹏,等.Graves病的介入治疗的病理及临床研究[J].中华放射学杂志,2000,34:452-455.
[10]高不郎,赵卫.甲状腺动脉栓塞治疗Graves病的现状及存在的问题[J].介入放射学杂志,2005,14:436-439.
[11]高不郎,赵卫,黄建强,等.Graves病动脉栓塞治疗并发症分析[J].介入放射学杂志,2006,15:457-459.
[12]Phelps E,Wu PQ,Bretz J,et al.Thyroid cell apoptosis-A new understanding of thyroid autoimmunity[J].Endocrinol Metab Clin N Am,2000,29:375-388.
[13]Arscott PL,Knapp J,Rymaszewski M,et al.Fas(Apo-1,CD95)-mediated apoptosis in thyroid cell is regulated by a labile protein inhibitor[J].Endocrinology,1997,138:5019-5027.
[14]Hiromatsu Y,Hoshino T,Yagita H,et al.Functional Fas ligand expression in thyrocytes from patients with Graves disease[J].J Clin Endocrinol Metab,1999,84:2896-2902
[15]Kawakami A,Eguchi K,Matsuoka N,et al.Thyroid7stimulating hormone inhibits Fas antigen mediated apoptosis of human thyrocytes invitro[J].Endocrinology,1996,137:3163-3169.
[16]Yin XM,Oltvai ZN,Korsmeyer SJ.BH l and BH2domains of bcl-2are required for inhibition of apoptosis and heterodimerization with Bax[J].Nature,1994,369:312-313.

相似文献/References:

[1]杨金炜,李冠海,张明德. 左冠状动脉窦瘤一例[J].介入放射学杂志,2012,(02):152.
 YANG Jin-wei,LI Guan-hai,ZHANG Ming-de..Aneurysm of the left coronary sinus: report of one case[J].journal interventional radiology,2012,(08):152.
[2]夏冰,侯庆峰,王兢,等.股骨头缺血性坏死介入治疗的护理[J].介入放射学杂志,2000,(03):148.
[3]刘建民 洪波 许奕 黄清海 赵文元 秦永文 周晓平.血管内支架治疗颅内动脉瘤[J].介入放射学杂志,2001,(04):195.
[4]史跃,高从敬,孟宪俊,等.颅内动脉溶栓联合机械碎栓治疗急性脑梗死[J].介入放射学杂志,2008,(05):309.
 SHI Yue,MENG Xianjun,CAI Tingjiang,et al.Intracranial arterial thrombolysis and mechanical fragmentation in patients with acute infarction[J].journal interventional radiology,2008,(08):309.
[5]王彬,闫东,刘德忠,等.胰腺癌不同治疗模式的疗效分析[J].介入放射学杂志,2008,(06):404.
 WANG Bin,YANG Dong,LIU Dezhong,et al.Analysis of different therapeutic programs for patients with pancreatic carcinoma[J].journal interventional radiology,2008,(08):404.
[6]田民,靳梅,陈宦君,等.鼻泪管支架植入术的改良方法[J].介入放射学杂志,2008,(06):441.
 TIAN Min,JIN Mei,CHEN Huanjun,et al.Modified nasolacrimal duct stenting[J].journal interventional radiology,2008,(08):441.
[7]李槐,刘德忠,闫东.胰腺癌的介入诊疗[J].介入放射学杂志,2008,(06):381.
 LI Huai,LIU Dezhong,YAN Dong.Interventional therapy for pancreatic carcinoma[J].journal interventional radiology,2008,(08):381.
[8]宋恬,殷士蒙,孙荣跃,等.探讨介入治疗对晚期胰腺癌的疗效[J].介入放射学杂志,2008,(06):411.
 SONG Tian,YIN Shimeng,SUN Rongyue,et al.The efficacy discussion of interventional therapy for advanced pancreatic carcinoma[J].journal interventional radiology,2008,(08):411.
[9]侯国欣,仝现州,王志伟,等.双点穿刺阻流取栓与单纯导管吸栓治疗急性下肢动脉栓塞的对比研究[J].介入放射学杂志,2008,(06):397.
 HOU Guoxin,TONG Xianzhou,WANG Zhiwei,et al.Comparison of obstructing blood flow interventional embolectomy and simple interventional embolectomy for acute lower limb arterial embolism[J].journal interventional radiology,2008,(08):397.
[10]郑家平,邵国良,俞炎平,等.介入化疗治疗晚期恶性胰岛细胞瘤:附4例报道[J].介入放射学杂志,2008,(06):408.
 ZHENG Jiaping,SHAO Guoliang,YU Yanping,et al.Transcatheter arterial infusing chemotherapy for advanced malignant pancreatic islet cell tumors:four cases report[J].journal interventional radiology,2008,(08):408.
[11]易根发,赵卫,杨慧英,等.CT引导甲状腺穿刺活检术的应用[J].介入放射学杂志,2007,(08):541.
 YI Gen-fa,ZHAO Wei,YANG Hui-ying,et al.Application of CT-guided percutaneous thyroid biopsy in basic study of interventional therapy for Graves disease[J].journal interventional radiology,2007,(08):541.
[12]朱高红,赵卫,袁卫红,等.介入栓塞与131I治疗Graves病近期疗效的对比分析[J].介入放射学杂志,2010,(03):184.
 ZHU Gaohong,ZHAO Wei,YUAN Weihong,et al.Comparison of short-term effects between interventional embolization treatment and iodine-131therapy for Graves' hyperthyroidism[J].journal interventional radiology,2010,(08):184.

备注/Memo

备注/Memo:
收稿日期:2006-11-27
基金项目:云南省自然科学基金重点项目(2002C0012Z)
更新日期/Last Update: 2007-08-15